AVR 2.97% $12.15 anteris technologies ltd

annual general meeting review, page-22

  1. 445 Posts.
    lightbulb Created with Sketch. 2
    "No, the earlier date (January) was my own calculations from the the date the FDA submission was lodged (which is typical for a medical device such as Cardiocel.)"

    Ok fair enough. I say then they are just giving a conservative estimate of when approval will happen. No good saying early 2014 if there are some unexpected delays. This way if it does come "early" in 2014, it should see the SP soar.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.